PMID: 11325441Apr 28, 2001Paper

Orbital lymphoma: radiotherapy outcome and complications

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
S L StaffordT M Habermann

Abstract

Orbital non-Hodgkin's lymphomas (NHL) have traditionally been treated with radiation. Forty-eight patients presenting with orbital NHL were treated with radiation and were evaluated for local control, overall survival, cause-specific survival, and complications. Forty-five patients had low-grade and 3 patients had intermediate-grade histologic findings. Orbit-only disease occurred in 22 patients, the conjunctiva in 16, both in five, and lacrimal gland only in five. Patient age ranged from 35 to 94 years (median, 68). Ann Arbor stages were cIEA (34), cIIEA (six), cIIIEA (two), and cIVEA (six). Radiation doses ranged between 15 and 53.8 Gy (median, 27.5 Gy). Follow-up ranged from 0.14 to 18.23 years (median, 5.35). Median overall survival and cause-specific survival were 6.5 and 15.5 years, respectively. Patients with clinical stage I or II disease had significantly better overall and cause-specific survival than patients with stage III or IV disease. Ten-year relapse-free survival in 41 patients with stage I or II disease was 66%. However, there was continued downward pressure on relapse-free survival out to 18 years. One local failure occurred. Twenty-five patients sustained acute complications. There were 17 minor and four maj...Continue Reading

References

Nov 1, 1976·International Journal of Radiation Oncology, Biology, Physics·Y H Kim, J V Fayos
Sep 1, 1991·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J G LetschertH Bartelink
Oct 1, 1991·The British Journal of Ophthalmology·M ViebahnM D Osterloh
Apr 1, 1991·International Journal of Radiation Oncology, Biology, Physics·K J MinehanJ D Earle
Dec 1, 1988·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·E M BessellR A Whitelocke
Feb 1, 1971·The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine·S C FosterP K Tretter
Mar 1, 1984·International Journal of Radiation Oncology, Biology, Physics·P J Fitzpatrick, S Macko
Jul 1, 1984·International Journal of Radiation Oncology, Biology, Physics·B JerebJ Kutcher
Feb 15, 1995·International Journal of Radiation Oncology, Biology, Physics·C K ChaoM Smith
Nov 15, 1994·International Journal of Radiation Oncology, Biology, Physics·J T ParsonsR R Million
Nov 15, 1994·International Journal of Radiation Oncology, Biology, Physics·J T ParsonsR R Million
Nov 15, 1994·International Journal of Radiation Oncology, Biology, Physics·J T ParsonsR R Million
May 1, 1994·Survey of Ophthalmology·T Kivelä, A Tarkkanen
Apr 30, 1993·International Journal of Radiation Oncology, Biology, Physics·M C Smitt, S S Donaldson
Jan 1, 1996·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·O EsikA Kaneko
Apr 29, 1999·International Journal of Radiation Oncology, Biology, Physics·T W BolekN P Mendenhall

❮ Previous
Next ❯

Citations

Jun 1, 2005·International Journal of Radiation Oncology, Biology, Physics·Ping ZhouPeter M Mauch
Sep 5, 2002·American Journal of Ophthalmology·Charmaine HonWing Y Au
Nov 7, 2001·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·S AhmadP N Plowman
Oct 16, 2002·International Journal of Radiation Oncology, Biology, Physics·Sudershan BhatiaB-Chen Wen
Feb 28, 2003·International Journal of Radiation Oncology, Biology, Physics·Sylvie MartinetRené Olivier Mirimanoff
Aug 12, 2003·International Journal of Radiation Oncology, Biology, Physics·Masatoshi HasegawaTakashi Nakano
Nov 25, 2003·International Journal of Radiation Oncology, Biology, Physics·Claire Y FungJudith A Ferry
Oct 18, 2005·Cornea·Stefano BarabinoReza Dana
Jul 3, 2008·Anti-cancer Drugs·Didier DecaudinLivia Lumbroso-Le Rouic
Sep 5, 2008·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·Volker W Stieber
Apr 18, 2009·Blood·Alexandra Stefanovic, Izidore S Lossos
Mar 20, 2013·World Journal of Surgical Oncology·André M EckardtNils-Claudius Gellrich
Dec 9, 2009·Radiation Oncology·Luigi De CiccoRoberto Pacelli
Feb 25, 2009·Indian Journal of Ophthalmology·B S Yadav, S C Sharma
May 5, 2012·Oman Journal of Ophthalmology·Natasha TownsendMitchell R Smith
Feb 10, 2016·Critical Reviews in Oncology/hematology·Ombretta AnnibaliGiuseppe Avvisati
Feb 2, 2011·International Journal of Radiation Oncology, Biology, Physics·V Swetha E JeganathanMichael P MacManus
Feb 11, 2010·Journal of Pediatric Ophthalmology and Strabismus·Shahar FrenkelMary Lou Schmidt
Jan 13, 2009·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Natsuo TomitaAkinori Takada
Oct 31, 2008·International Journal of Radiation Oncology, Biology, Physics·Karin MullerGré P M Luyten
Oct 28, 2008·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Heerim NamWon Seog Kim
Apr 22, 2008·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Hideomi YamashitaKuni Ohtomo
Feb 3, 2007·Journal of Cranio-maxillo-facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery·Hubert WanyuraAgnieszka Smolarz-Wojnowska
Feb 14, 2004·European Journal of Haematology·Uta SchickWerner Hassler
May 10, 2007·Acta Ophthalmologica Scandinavica·Shane R DurkinDinesh Selva
Oct 31, 2016·Survey of Ophthalmology·Michelle E WilsonJurij R Bilyk
Oct 12, 2015·International Journal of Radiation Oncology, Biology, Physics·Emma B HollidaySteven J Frank
Oct 2, 2015·BioMed Research International·Ombretta AnnibaliGiuseppe Avvisati
Oct 10, 2007·Expert Opinion on Pharmacotherapy·Andres J M FerreriMaurilio Ponzoni
Oct 2, 2012·Leukemia & Lymphoma·Krystel H TranAndrew Wirth
Aug 9, 2005·Leukemia & Lymphoma·Inci AlacaciogluBulent Undar
Jun 7, 2011·International Journal of Radiation Oncology, Biology, Physics·Jayant Sastri GodaRichard W Tsang
May 18, 2012·International Journal of Radiation Oncology, Biology, Physics·Megha KaushikScott Stafford
Apr 23, 2016·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Andi K CaniRajesh C Rao
Dec 3, 2014·Clinical Oncology : a Journal of the Royal College of Radiologists·D K WoolfP N Plowman
Oct 26, 2016·Archivos de la Sociedad Española de Oftalmología·M L Luque Valentin-FernandezI Rodríguez Jiménez
Mar 5, 2016·Practical Radiation Oncology·Michael S BinkleyRichard T Hoppe
May 3, 2016·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·L GastaudJ Doyen
May 11, 2016·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Laila KönigKlaus Herfarth
Dec 15, 2005·Seminars in Ophthalmology·Patricia S Tsai, Kathryn A Colby

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Radiation Oncology, Biology, Physics
P W GrigsbyJ Rader
Archives of Otolaryngology--head & Neck Surgery
Stephanie M PerkinsWade L Thorstad
International Journal of Radiation Oncology, Biology, Physics
Cécile OrtholanAdel Courdi
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
Adel CourdiIsabelle Birtwisle-Peyrottes
© 2021 Meta ULC. All rights reserved